Early cholesterol treatment for heart attack patients
Treatments studied
Part of Heart & circulation clinical trials.
This study tests whether a newer cholesterol-lowering injection, given early after a heart attack, helps keep the plaque in your arteries stable and reduces future risk. It compares the new medicine added to your usual statin treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 85 years old
- You are currently in the hospital for a heart attack or chest pain that gets worse quickly
- You are having (or just had) a procedure to open a blocked artery, and your doctor used a special camera called OCT to get clear pictures
- Your 'bad' cholesterol (LDL) is at a certain level based on your current cholesterol medicine – the study team will check this
- You can come back for a follow-up heart scan and camera test after 12 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two approaches to lowering 'bad' cholesterol (LDL-C) in people hospitalized with acute coronary syndrome (a heart attack or unstable angina). One approach uses two medications (a statin plus another pill), and the other uses three (adding an injectable medicine). The goal is to see if the triple therapy lowers cholesterol more effectively and helps prevent future heart problems.
This study compares two cholesterol treatment approaches after a heart attack: a lower dose combination versus a higher dose single medicine. It aims to see which option works well and is tolerable for people after a treated heart attack.
This study tests whether giving a new cholesterol-lowering drug, inclisiran, early during a hospital stay after a heart attack can help lower bad cholesterol (LDL) more effectively than usual care. It may reduce the risk of future heart problems.
This study tests whether starting a cholesterol-lowering injection (a PCSK9 inhibitor) early after a heart attack can slow or shrink the buildup of plaque in other heart arteries that are not the one that was stented. If you have two other arteries with mild blockages, this treatment might help prevent future heart problems.
This study tests an extra medication (inclisiran) added to your usual cholesterol-lowering treatment, compared to usual treatment alone, to see if it further lowers 'bad' cholesterol after a recent heart attack.
This study tests whether adding an extra cholesterol-lowering drug (bempedoic acid) to the usual treatment soon after a heart attack or related event can lower 'bad' cholesterol more effectively. It may help reduce the risk of future heart problems.
Hear when a new Acute Coronary Syndromes (ACS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.